19.34
3.64%
0.68
시간 외 거래:
19.56
0.22
+1.14%
Forte Biosciences Inc (FBRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
100.00%
-
|
1.124 | - | - | - |
Operating Expenses |
22.30%
7.804
|
6.381 | 10.22 | 9.034 | 6.855 |
Operating Income/Loss |
22.30%
-7.804
|
-6.381 | -10.22 | -9.034 | -6.855 |
Income/Loss From Continuing Operations Before Tax |
127.76%
-7.42
|
26.73 | -9.955 | -8.896 | -6.753 |
Income/Loss From Continuing Operations After Tax |
26.36%
-7.42
|
-5.872 | -9.955 | -8.896 | -6.753 |
Net Income/Loss
|
26.36%
-7.42
|
-5.872 | -9.955 | -8.896 | -6.753 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Earnings Per Share |
300.00%
-0.16
|
-0.04 | -0.26 | -0.42 | -0.32 |
Diluted Earnings Per Share |
300.00%
-0.16
|
-0.04 | -0.26 | -0.42 | -0.32 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):